If you are an 18 years or older and been diagnosed with moderate to severe Major Depressive Disorder (MDD) , you could earn up to $1,500 by participating in a clinical trial for a new investigational drug called azetukalner.
It only takes a minute to see if you qualify.
MDD is a widespread disorder and one of the leading causes of disability in the world. There are
many antidepressant treatments available and most of them work in a similar way in the brain.
This new study drug acts on the brain in a different way than most existing antidepressants and
could potentially benefit patients by providing an additional new treatment option.
This study will compensate you for your participation. Complete the form below to apply today!
Just fill out the form below to gain access to this paid study. You will need to complete a survey to see if you are eligible!
There are other criteria that you will need
to meet to qualify, which the study team will
discuss with you.
Copyright © 2022 Clinical study connection, a division of Georgia Medical Consulting - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.